Search…

Lates News

18/06/2025

VistaGen Therapeutics (VTGN.US): The Q4 2025 financial report achieved revenue of $486,000, compared to the previous value of $197,300, and an expected value of $209,330; earnings per share were -$0.44, compared to the previous value of -$0.25, and an expected value of -$0.49.

Latest

now

Pan Gongsheng: Currently, the People's Bank of China has signed bilateral currency swap agreements with central banks or monetary authorities in more than 30 countries and regions.

1 m ago

There are currently 23 hydrological stations in Guangdong Province that have exceeded the warning level.

2 m ago

Hong Kong Stock Market anomaly | Fourth Paradigm (06682.HK) rises nearly 4% against the market trend. The company's goal is to enter the fast growth track and is dedicated to focusing on "Agent+ World Model".

2 m ago

Computing power hardware stocks are active again, Shengyi Electronics has risen more than 10% to achieve a new historical high.

3 m ago

B station has connected to Ali's large model "Tongyi Qianwen 3" and VL models to create data insight intelligence agent InsightAgent to help improve the efficiency of commercial platforms such as "Huahuo" and "Bida". It is reported that during the 618 period, the transaction efficiency of Huahuo's business orders increased by more than 5 times, and the data insight efficiency of Bida increased by more than 3 times.

See all latest